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Kidney disease is a global public health problem that 
affects more than 750 million persons worldwide [1]. 
The burden of kidney disease varies substantially across 
the world, as does its detection and treatment. Although 
the magnitude and impact of kidney disease is better 
defined in developed countries, emerging evidence sug-
gests that developing countries have a similar or even 
greater kidney disease burden [2].
In many settings, rates of kidney disease and the provision 
of its care are defined by socioeconomic, cultural, and 
political factors, leading to significant disparities in disease 
burden, even in developed countries [3]. These disparities 
exist across the spectrum of kidney disease – from pre-
ventive efforts to curb development of acute kidney 
injury (AKI) or chronic kidney disease (CKD), to screening 
for kidney disease among persons at high risk, to access 
to subspecialty care and treatment of kidney failure 
with renal replacement therapy (RRT). World Kidney 
Day 2019 offers an opportunity to raise awareness of 
kidney disease and highlight disparities in its burden and 
current state of global capacity for prevention and 
management. In this editorial, we highlight these dis-
parities and emphasize the role of public policies and 
organizational structures in addressing them. We outline 
opportunities to improve our understanding of disparities 
in kidney disease, the best ways for them to be addressed, 
and how to streamline efforts toward achieving kidney 
health equity across the globe.
bUrDEN OF KIDNEY DIsEAsE
Availability of data reflecting the full burden of kidney 
disease varies substantially because of limited or 
inconsistent data collection and surveillance practices 
worldwide (Table 1) [4]. Whereas several countries have 
national data collection systems, particularly for end-
stage renal disease (ESRD) (e.g., United States Renal 
Data System, Latin American Dialysis and Renal Trans-
plant Registry, and Australia and New Zealand Dialysis 
and Transplant Registry), high-quality data regarding non-
dialysis CKD is limited, and often the quality of ESRD 
data is quite variable across settings. This situation is of 
particular concern in low-income countries. For example, 
a meta-analysis of 90 studies on CKD burden conducted 
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4across Africa showed very few studies (only 3%) with 
robust data [5]. The provision of adequate resources and a 
workforce to establish and maintain surveillance systems 
(e.g., screening programs and registries) is essential and 
requires substantial investment [6]. Incorporating kidney 
disease surveillance parameters in existing chronic disease 
prevention programs might enhance global efforts toward 
obtaining high-quality information on kidney disease burden 
and attendant consequences.
In addition to a need for functional surveillance systems, 
the global importance of kidney disease (including AKI 
and CKD) is yet to be widely acknowledged, making it a 
neglected disease on the global policy agenda. For instance, 
the World Health Organization (WHO) Global Action 
Plan for the Prevention and Control of Non-Communi-
cable Diseases (NCDs) (2013) focuses on cardiovascular 
diseases, cancer, chronic respiratory diseases, and diabetes 
but not kidney disease, despite advocacy efforts by rele-
vant stakeholders such as the International Society of 
Nephrology and the International Federation of Kidney 
Foundations through activities such as World Kidney Day. 
This situation is quite concerning because estimates from 
the Global Burden of Disease study in 2015 showed that 
around 1.2 million people were known to have died of 
CKD [7], and more than 2 million people died in 2010 
because they had no access to dialysis. It is estimated that 
another 1.7 million die from AKI on an annual basis [8,9]. 
It is possible, therefore, that kidney disease may contribute 
to more deaths than the 4 main NCDs targeted by the 
current NCD Action Plan.
rIsK FActOrs FOr KIDNEY DIsEAsE
Data in recent decades have linked a host of genetic, 
environmental, sociodemographic, and clinical factors to 
risk of kidney disease. The population burden of kidney 
disease is known to correlate with socially defined factors 
in most societies across the world. This phenomenon is 
better documented in high-income countries, where racial/
ethnic minority groups and people of low socioeconomic 
status carry a high burden of disease. Extensive data have 
demonstrated that racial and ethnic minorities (e.g., African 
Americans in the United States, Aboriginal groups in 
Canada and Australia, Indo-Asians in the United Kingdom, 
and others) are affected disproportionately by advanced 
and progressive kidney disease [10-12]. The associations of 
socioeconomic status and risk of progressive CKD and 
eventual kidney failure also have been well described, with 
persons of lower socioeconomic status bearing the greatest 
burden [13,14].
Recent works have associated apolipoprotein L1 risk 
variants [15,16] with increased kidney disease burden 
among persons with African ancestry. In Central America 
and Southeastern Mexico, Mesoamerican nephropathy 
(also referred to as CKD of unknown causes) has emerged 
as an important cause of kidney disease. While multiple 
exposures have been studied for their potential role in 
CKD of unknown causes, recurrent dehydration and heat 
stress are common denominators in most cases [17]. 
Other perhaps more readily modifiable risk factors for 
kidney disease and CKD progression that disproportion-
ately affect socially disadvantaged groups also have been 
identified, including disparate rates and poor control of 
clinical risk factors such as diabetes and hypertension, as 
well as lifestyle behaviors.
Diabetes is the leading cause of advanced kidney disease 
worldwide [18]. In 2016, 1 in 11 adults worldwide had dia-
betes and more than 80% were living in low- and middle-
income countries [19] where resources for optimal care 
are limited. Hypertension is also estimated to affect 
1 billion persons worldwide [20] and is the second leading 
Burden, access, and disparities in kidney disease
table 1.  World Bank country group chronic kidney disease 
gaps.
CKD care
Low-
income 
countries 
(%)
Lower-
middle-
income 
countries 
(%)
Upper 
middle-
income 
countries 
(%)
High-
income 
countries 
(%)
Governmental 
recognition 
of CKD as a 
health priority
59 50 17 29
Government 
funds all 
aspects of 
CKD care
13 21 40 53
Availability 
of CKD 
management 
and referral 
guidelines 
(international, 
national, or 
regional)
46 73 83 97
Existence of 
current CKD 
detection 
programs
6 24 24 32
Availability 
of dialysis 
registries
24 48 72 89
Availability 
of academic 
centers 
for renal 
clinical trial 
management
12 34 62 63
CKD, chronic kidney disease.
Data from Bello et al. [4]
5attributed cause of CKD [18]. Hypertension control is 
important for slowing CKD progression and decreasing 
mortality risk among persons with or without CKD. Hyper-
tension is present in more than 90% of persons with 
advanced kidney disease [18], yet racial/ethnic minorities 
and low-income persons with CKD who live in high-income 
countries have poorer blood pressure control than their 
more socially advantaged counterparts [21].
Lifestyle behaviors, including dietary patterns, are strongly 
influenced by socioeconomic status. In recent years, several 
healthful dietary patterns have been associated with 
favorable CKD outcomes [22]. Low-income persons often 
face barriers to healthful eating that may increase their risk 
of kidney disease [23-25]. People of low socioeconomic 
status often experience food insecurity (i.e., limited access 
to affordable nutritious foods), which is a risk factor for 
CKD [26] and progression to kidney failure [27]. In low-
income countries, food insecurity may lead to under-
nutrition and starvation, which has implications for the 
individual and, in the case of women of child-bearing age, 
could lead to their children having low birth weight and 
related sequelae, including CKD [28]. Rates of under-
nourishment are as high as 35% or more in countries such 
as Haiti, Namibia, and Zambia [29]. However, in high-
income countries, food insecurity is associated with over-
nutrition, and persons with food insecurity have increased 
risk of overweight and obesity [30,31]. Further, food 
insecurity has been associated with several diet-related 
conditions, including diabetes and hypertension.
AcUtE KIDNEY INJUrY
AKI is an under-detected condition that is estimated to 
occur in 8% to 16% of hospital admissions [32] and is now 
well established as a risk factor for CKD [33]. Disparities 
in AKI risk are also common, following a pattern similar 
to that observed in persons with CKD [34]. AKI related 
to nephrotoxins, alternative (traditional) medicines, infec-
tious agents, and hospitalizations and related procedures 
are more pronounced in low-income and lower-middle-
income countries and contribute to increased risk of 
mortality and CKD in those settings [35]. Importantly, 
the majority of annual AKI cases worldwide (85% of more 
than 13 million cases) are experienced in low-income and 
lower-middle-income countries, leading to 1.4 million 
deaths [36].
HEALtH POLIcIEs AND FINANcING OF 
KIDNEY DIsEAsE cArE
Because of the complex and costly nature of kidney disease 
care, its provision is tightly linked with the public policies 
and financial status of individual countries. For example, 
gross domestic product is correlated with lower dialysis-to-
transplantation ratios, suggesting greater rates of kidney 
transplantation in more financially solvent nations. In several 
high-income countries, universal health care is provided by 
the government and includes CKD and ESRD care. In other 
countries, such as the United States, ESRD care is publicly 
financed for citizens; however, optimal treatment of CKD 
and its risk factors may not be accessible for persons lacking 
health insurance, and regular care of undocumented immi-
grants with kidney disease is not covered [37]. In low-
income and lower-middle-income countries, neither CKD 
nor ESRD care may be publicly financed, and CKD pre-
vention efforts are often limited. In several such countries, 
collaborations between public and private sectors have 
emerged to provide funding for RRT. For example, in 
Karachi, Pakistan, a program of dialysis and kidney trans-
plantation through joint community and government 
funding has existed for more than 25 years [38].
In many settings, persons with advanced CKD who have no 
or limited public or private sector funding for care shoulder 
a substantial financial burden. A systematic review of 260 
studies including patients from 30 countries identified sig-
nificant challenges, including fragmented care of indeter-
minate duration, reliance on emergency care, and fear of 
catastrophic life events because of diminished financial 
capacity to withstand them [39]. Authors of another study 
conducted in Mexico found that patients and families were 
burdened with having to navigate multiple health and social 
care structures, negotiate treatments and costs, finance 
their health care, and manage health information [40]. 
Challenges may be even greater for families of children 
with ESRD, because many regions lack qualified pediatric 
care centers.
OrGANIZAtION AND strUctUrEs FOr 
KIDNEY DIsEAsE cArE
The lack of recognition and therefore the absence of a 
global action plan for kidney disease partly explains the 
substantial variation in structures and capacity for kidney 
care around the globe. This situation has resulted in varia-
tions in government priorities, health care budgets, care 
structures, and human resource availability [41]. Effective 
and sustainable advocacy efforts are needed at global, 
regional, and national levels to get kidney disease recognized 
and placed on the global policy agenda.
In 2017, the International Society of Nephrology collected 
data on country-level capacity for kidney care delivery using 
a survey, the Global Kidney Health Atlas [4], which aligned 
with the WHO’s building blocks of a health system. The 
Global Kidney Health Atlas highlights limited awareness 
of kidney disease and its consequences and persistent 
inequities in resources required to tackle the burden of 
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6kidney disease across the globe. For example, CKD was 
recognized as a health care priority by government in only 
36% of countries that participated in this survey. The 
priority was inversely related to income level: CKD was a 
health care priority in more than half of low-income and 
lower-middle-income countries but in less than 30% of 
upper-middle-income and high-income countries.
Regarding capacity and resources for kidney care, many 
countries still lack access to basic diagnostics, a trained 
nephrology workforce, universal access to primary health 
care, and RRT technologies. Low-income and lower-
middle-income countries, especially in Africa, had limited 
services for the diagnosis, management, and monitoring of 
CKD at the primary care level, with only 12% having serum 
creatinine measurement, including estimated glomerular 
filtration rate. Twenty-nine percent of low-income countries 
had access to qualitative urinalysis using urine test strips; 
however, no low-income country had access to urine 
albumin-to-creatinine ratio or urine protein-to-creatinine 
ratio measurements at the primary care level. Across all 
world countries, availability of services at the secondary/
tertiary care level was considerably higher than at the 
primary care level (Figure 1a and b) [4,42].
rENAL rEPLAcEMENt tHErAPIEs
The distribution of RRT technologies varied widely. On 
the surface, all countries reported having long-term hemo-
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Figure 1.  Health care services for identification and management of chronic kidney disease by country income 
level.  (a) Primary care (i.e., basic health facilities at community levels [e.g., clinics, dispensaries, and small local hospitals]).  
(b) Secondary/specialty care (i.e., health facilities at a level higher than primary care [e.g., clinics, hospitals, and academic centers]). 
eGFR, estimated glomerular filtration rate; HbA1C, glycated hemoglobin; UACR, urine albumin-to-creatinine ratio; UPCR, urine 
protein-to-creatinine ratio. Data from Bello et al. [4] and Htay et al.[42].
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7dialysis services, and more than 90% of countries reported 
having short-term hemodialysis services. However, access 
to and distribution of RRT across countries and regions 
was highly inequitable, often requiring prohibitive out-of-
pocket expenditure, particularly in low-income regions. For 
instance, more than 90% of upper-middle-income and 
high-income countries reported having chronic peritoneal 
dialysis services, whereas these services were available in 
64% and 35% of low-income and lower-middle-income 
countries, respectively. In comparison, acute peritoneal 
dialysis had the lowest availability across all countries. More 
than 90% of upper-middle-income and high-income coun-
tries reported having kidney transplant services, with more 
than 85% of these countries reporting both living and 
deceased donors as the organ source. As expected, low-
income countries had the lowest availability of kidney 
transplant services, with only 12% reporting availability, and 
live donors as the only source.
WOrKFOrcE FOr KIDNEY cArE
Considerable international variation was also noted in the 
distribution of the kidney care workforce, particularly 
nephrologists. The lowest density (<5 nephrologists per 
million population) was very common in low-income 
countries, whereas the highest density (>15 nephrologists 
per million population) was reported mainly in high-income 
countries (Figure 2) [4,43,44]. Most countries reported 
nephrologists as primarily responsible for both CKD and 
AKI care. Primary care physicians had more responsibility 
for CKD care than for AKI care, as 64% of countries 
reported that primary care physicians are primarily 
responsible for CKD care and 35% reported that they are 
responsible for AKI care. Intensive care specialists were 
primarily responsible for AKI in 75% of countries, likely 
because AKI is typically treated in hospitals. However, only 
45% of low-income countries reported that intensive care 
specialists were primarily responsible for AKI, compared 
with 90% of high-income countries; this discrepancy may 
be due to a general shortage of intensive care specialists in 
low-income countries.
The appropriate number of nephrologists in a country 
depends on many factors, including need, priority, and 
resources, and as such there is no global standard with 
respect to nephrologist density. Regardless, the demon-
strated low density in low-income countries calls for con-
cern as nephrologists are essential to provide leadership in 
kidney disease care, and a lack of nephrologists may result 
in adverse consequences for policy and practice. However, 
it is quite encouraging that the number of nephrologists 
and nephropathologists is rising in low-income and lower-
middle-income countries, in part thanks to fellowship 
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Figure 2.  Nephrologist availability (density per million population) compared with physician, nursing, and 
pharmaceutical personnel availability by country income level. Pharmaceutical personnel include pharmacists, 
pharmaceutical assistants, and pharmaceutical technicians. Nursing and midwifery personnel include professional nurses, 
professional midwives, auxiliary nurses, auxiliary midwives, enrolled nurses, enrolled midwives, and related occupations such as 
dental nurses. A logarithmic scale was used for the x-axis [log(x+1)] because of the large range in provider density. Data from Bello 
et al. [4], Osman et al. [43], and the World Health Organization (for pharmaceutical personnel: http://apps.who.int/gho/data/view.
main.PHARMS and http://apps.who.int/gho/data/node.main-amro.HWF?lang=en, for nursing and midwifery personnel: http://apps.
who.int/gho/data/view.main.NURSES, for physicians: http://apps.who.int/gho/data/view.main.92000) [44].
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8programs supported by international nephrology organiza-
tions [45]. It is important to note that the role of a 
nephrologist may differ depending on how the health care 
system is structured. The density statistic merely represents 
the number of nephrologists per million population and 
provides no indication of the adequacy to meet the needs 
of the population or quality of care, which depends on 
volume of patients with kidney disease and other workforce 
support (e.g., availability of multidisciplinary teams).
For other care providers essential for kidney care, inter-
national variations exist in distribution (availability and 
adequacy). Overall, provider shortages were highest for 
renal pathologists, vascular access coordinators, and dieti-
tians (with 86%, 81%, and 78% of countries reporting a 
shortage, respectively), and the shortages were more 
common in low-income countries. Few countries (35%) 
reported a shortage in laboratory technicians. This informa-
tion highlights significant inter- and intra-regional variability 
in the current capacity for kidney care across the world. 
Important gaps in awareness, services, workforce, and 
capacity for optimal care delivery were identified in many 
countries and regions [4]. The findings have implications 
for policy development with regard to establishment of 
robust kidney care programs, particularly for low-income 
and lower-middle-income countries [46]. The Global 
Kidney Health Atlas has therefore provided a baseline 
understanding of where countries and regions stand with 
respect to several domains of the health system, thus 
allowing the monitoring of progress through the imple-
mentation of various strategies aimed at achieving equitable 
and quality care for the many patients with kidney disease 
across the globe.
How could this information be used to mitigate existing 
barriers to kidney care? First, basic infrastructure for ser-
vices must be strengthened at the primary care level for 
early detection and management of AKI and CKD across 
all countries [46]. Second, although optimal kidney care 
obviously should emphasize prevention to reduce adverse 
consequences of kidney disease at the population level, 
countries (particularly low-income and lower-middle-
income countries) should be supported at the same time 
to adopt more pragmatic approaches in providing RRT. For 
example, acute peritoneal dialysis could be an attractive 
modality for AKI, because this type of dialysis is as effective 
as hemodialysis, requires far less infrastructure, and can be 
performed with solutions and catheters adapted to local 
resources [47]. Third, kidney transplantation should be 
encouraged through increased awareness among the public 
and political leaders across countries, because this is the 
clinically optimal modality of RRT and it is also cost-effec-
tive, provided that costs of the surgery and long-term 
medication and follow-up are made sustainable through 
public (and/or private) funding [48]. Currently, most kidney 
transplants are conducted in high-income countries, in part 
because of lack of resources and knowledge in low-income 
and lower-middle-income countries, as well as cultural 
practices and absence of legal frameworks governing organ 
donation [48].
cONcLUsIONs
Socially disadvantaged persons experience a dispropor-
tionate burden of kidney disease worldwide. The provision 
and delivery of kidney care varies widely across the world. 
Achieving universal health coverage worldwide by 2030 
is one of the WHO Sustainable Development Goals. 
Although universal health coverage may not include all 
elements of kidney care in all countries (because this is 
usually a function of political, economic, and cultural 
factors), understanding what is feasible and important for a 
country or region with a focus on reducing the burden and 
consequences of kidney disease would be an important 
step toward achieving kidney health equity.
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